Shopping Cart
Remove All
Your shopping cart is currently empty
Bersiporocin is a novel prolyl-tRNA synthetase (PRS) inhibitor that exerts antifibrotic effects through downregulation of collagen synthesis and is well tolerated in the clinic. In cellular and animal models of idiopathic pulmonary fibrosis (IPF), DWN12088 significantly reduced collagen synthesis and improved lung function.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $475 | - | In Stock | |
| 5 mg | $1,430 | - | In Stock | |
| 10 mg | $2,380 | - | In Stock |
| Description | Bersiporocin is a novel prolyl-tRNA synthetase (PRS) inhibitor that exerts antifibrotic effects through downregulation of collagen synthesis and is well tolerated in the clinic. In cellular and animal models of idiopathic pulmonary fibrosis (IPF), DWN12088 significantly reduced collagen synthesis and improved lung function. |
| Targets&IC50 | PRS:≤100 nM |
| Synonyms | DWN12088, DWN 12088 |
| Molecular Weight | 328.24 |
| Formula | C15H19Cl2N3O |
| Cas No. | 2241808-52-4 |
| Smiles | C(CC[C@@H]1[C@@H](O)CCCN1)N2C=3C(N=C2)=C(Cl)C(Cl)=CC3 |
| Relative Density. | 1.46 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 100 mg/mL (304.66 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.